Literature DB >> 11897714

Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A.

Martine M L Deckers1, Rutger L van Bezooijen, Geertje van der Horst, Jakomijn Hoogendam, Chris van Der Bent, Socrates E Papapoulos, Clemens W G M Löwik.   

Abstract

During bone formation and fracture healing there is a cross-talk between endothelial cells and osteoblasts. We previously showed that vascular endothelial growth factor A (VEGF-A) might be an important factor in this cross-talk, as osteoblast-like cells produce this angiogenic factor in a differentiation-dependent manner. Moreover, exogenously added VEGF-A enhances osteoblast differentiation. In the present study we investigated, given the coupling between angiogenesis and bone formation, whether bone morphogenetic proteins (BMPs) stimulate osteoblastogenesis and angiogenesis through the production of VEGF-A. For this we used the murine preosteoblast-like cell line KS483, which forms mineralized nodules in vitro, and an angiogenesis assay comprising 17-d-old fetal mouse bone explants that have the ability to form tube-like structures in vitro. Treatment of KS483 cells with BMP-2, -4, and -6 enhanced nodule formation, osteocalcin mRNA expression, and subsequent mineralization after 18 d of culture. This was accompanied by a dose-dependent increase in VEGF-A protein levels throughout the culture period. BMP-induced osteoblast differentiation, however, was independent of VEGF-A, as blocking VEGF-A activity by a VEGF-A antibody or a VEGF receptor 2 tyrosine kinase inhibitor did not affect BMP-induced mineralization. To investigate whether BMPs stimulate angiogenesis through VEGF-A, BMPs were assayed for their angiogenic activity. Treatment of bone explants with BMPs enhanced angiogenesis. This was inhibited by soluble BMP receptor 1A or noggin. In the presence of a VEGF-A antibody, both unstimulated and BMP-stimulated angiogenesis were arrested. Conditioned media of KS483 cells treated with BMPs also induced a strong angiogenic response, which was blocked by antimouse VEGF-A but not by noggin. These effects were specific for BMPs, as TGF beta inhibited osteoblast differentiation and angiogenesis while stimulating VEGF-A production. These findings indicate that BMPs stimulate angiogenesis through the production of VEGF-A by osteoblasts. In conclusion, VEGF-A produced by osteoblasts in response to BMPs is not involved in osteoblast differentiation, but couples angiogenesis to bone formation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897714     DOI: 10.1210/endo.143.4.8719

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  148 in total

1.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.

Authors:  David G Winkler; May Kung Sutherland; James C Geoghegan; Changpu Yu; Trenton Hayes; John E Skonier; Diana Shpektor; Mechtild Jonas; Brian R Kovacevich; Karen Staehling-Hampton; Mark Appleby; Mary E Brunkow; John A Latham
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

Review 2.  Angiogenesis and marrow stromal cell fates: roles in bone strength.

Authors:  Dwight A Towler
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

3.  Bmp2 is required for odontoblast differentiation and pulp vasculogenesis.

Authors:  W Yang; M A Harris; Y Cui; Y Mishina; S E Harris; J Gluhak-Heinrich
Journal:  J Dent Res       Date:  2011-10-07       Impact factor: 6.116

4.  Reciprocal induction of human dermal microvascular endothelial cells and human mesenchymal stem cells: time-dependent profile in a co-culture system.

Authors:  M S Laranjeira; M H Fernandes; F J Monteiro
Journal:  Cell Prolif       Date:  2012-05-18       Impact factor: 6.831

5.  Effect of bone mesenchymal stem cells transplantation on the micro-environment of early osteonecrosis of the femoral head.

Authors:  Huanjin Song; Li Tao; Fang Wang; Weizhuo Wang; Yongchang Wei; Wenjun Shen; Fuling Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 6.  Overview of biological mechanisms and applications of three murine models of bone repair: closed fracture with intramedullary fixation, distraction osteogenesis, and marrow ablation by reaming.

Authors:  Beth Bragdon; Kyle Lybrand; Louis Gerstenfeld
Journal:  Curr Protoc Mouse Biol       Date:  2015-03-02

7.  Improvement in angiogenesis and osteogenesis with modified cannulated screws combined with VEGF/PLGA/fibrin glue in femoral neck fractures.

Authors:  Licheng Zhang; Lihai Zhang; Xia Lan; Meng Xu; Zhi Mao; Houchen Lv; Qi Yao; Peifu Tang
Journal:  J Mater Sci Mater Med       Date:  2014-01-17       Impact factor: 3.896

8.  Stress fracture healing: fatigue loading of the rat ulna induces upregulation in expression of osteogenic and angiogenic genes that mimic the intramembranous portion of fracture repair.

Authors:  Gregory R Wohl; Dwight A Towler; Matthew J Silva
Journal:  Bone       Date:  2008-10-07       Impact factor: 4.398

9.  Cell and Tissue Response to Polyethylene Terephthalate Mesh Containing Bone Allograft in Vitro and in Vivo.

Authors:  D Joshua Cohen; Lisa Ferrara; Marcus B Stone; Zvi Schwartz; Barbara D Boyan
Journal:  Int J Spine Surg       Date:  2020-10-29

10.  Osteogenic protein-1 overcomes inhibition of fracture healing in the diabetic rat: a pilot study.

Authors:  Louis S Kidder; Xinqian Chen; Andrew H Schmidt; William D Lew
Journal:  Clin Orthop Relat Res       Date:  2008-07-29       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.